Indian drug major Dr Reddy's Laboratories Limited has reached a settlement with the US government agencies for $ 5 million in a six-year-old case regarding the complaints of a potential harm from the package of blister-packed prescription products to children.
In June last year, the US Consumer Product Safety Commission (CPSC) had requested the US Department of Justice to impose a civil penalty on Dr Reddy's for alleged violations of provisions related to the child-resistant packaging in at least five prescription drugs.
While disagreeing with these accusations, the company on Tuesday said that it has chosen to settle
In June last year, the US Consumer Product Safety Commission (CPSC) had requested the US Department of Justice to impose a civil penalty on Dr Reddy's for alleged violations of provisions related to the child-resistant packaging in at least five prescription drugs.
While disagreeing with these accusations, the company on Tuesday said that it has chosen to settle